immunopotentiator

im·mu·no·po·ten·ti·a·tor

(im'yū-nō-pō-ten'shē-ā-tŏr),
Any of a wide variety of specific or nonspecific substances that on inoculation enhances or augments an immune response.
Mentioned in ?
References in periodicals archive ?
Comparative study on the immunopotentiator effect of ISA 201, ISA 61, ISA 50, ISA 206 used in trivalent foot and mouth disease vaccine.
This formulation aimed to act as an immunopotentiator to modify cellular and humoral immunity by antibodies and Th1/Th17 responses, proposed as adjuvant in topical vaccine, improving the specificity of the system against many bacterial pathogens of the oral mucosa.
An even more complex vector is the combination of nanoparticle technology and liposomes with biodegradable poly(DL-lactic-co-glycolic acid) (PLGA), cationic surfactant dimethyldioctadecylammonium (DDA) bromide, and the immunopotentiator TDB which promotes Th1 and Th17 [CD4.sup.+] T cell responses and enhanced specific serum antibodies [112].
Effect of epimedium polysaccharide-propolis flavone immunopotentiator on immunosuppression induced by cyclophosphamide in chickens.
Mastitis prevention is possible through treatment of buffer, antioxidant and immunopotentiator treatment.
Oshikawa et al., "Anti-tumor effect of an intratumoral administration of dendritic cells in combination with TS-1, an oral fluoropyrimidine anticancer drug, and OK-432, a streptococcal immunopotentiator: involvement of toll-like receptor 4," Journal of Immunotherapy, vol.
Therefore, it should have the potential as an effective modifier in therapy of leukemia and/or as an immunopotentiator.
(1982) reported already that a Streptococcal preparation, OK-432, as an immunopotentiator, activated complement via the alternative pathway in mouse serum.
In this context, the use of immunopotentiators, immune initiators or biological response modifiers (BRMs) that are capable of stimulating the immune cells that can identify tumour cells as foreign, eliminate and prevent carcinogenesis has gained prominence [11].
The most common treatment is only to relieve symptoms by supportive therapy and the use of antivirals, antibiotics, and immunopotentiators [1, 5].
All of them contain polysaccharides, those long-chain molecules composed of sugar units, which seem to be responsible for their action as immunopotentiators. Many ancient civilizations used mushrooms for more than just food.
Effects of non-specific immunopotentiators in experimental Schistosoma mansoni infection.